Inventor · disambiguated record
Thomas Kort
Also filed as: KORT THOMAS
7 granted patents·2 pending applications·25 citations·filing 2002–2022
79Inventor score
Files withNOVAVAX INC3INTEGRATED BIOTHERAPEUTIC VACCINES INC2ABVACC INC1INTEGRATED BIOTHERAPEUTICS INC1INVITROGEN CORP1
Top patents by PatentIndex Score
9 records- 0191US8992939B2Highly efficient influenza matrix (M1) proteinsSMITH GALE·Filed 2011·Granted Mar 31, 2015·16 cites·20 claims
- 0289US9464276B2Highly efficient influenza matrix (M1) proteinsNOVAVAX INC·Filed 2015·Granted Oct 11, 2016·8 cites·16 claims
- 0375US9951317B2Highly efficient influenza matrix (M1) proteinsNOVAVAX INC·Filed 2016·Granted Apr 24, 2018·1 cites·20 claims
- 0463US10544399B2Highly efficient influenza matrix (M1) proteinsNOVAVAX INC·Filed 2018·Granted Jan 28, 2020·0 cites·20 claims
- 0561US11826412B2Immunogenic composition comprising a fusion peptide derived from superantigen toxoidsABVACC INC·Filed 2022·Granted Nov 28, 2023·0 cites·20 claims
- 0652US11260120B2Immunogenic composition comprising a fusion peptide derived from superantigen toxoidsINTEGRATED BIOTHERAPEUTIC VACCINES INC·Filed 2018·Granted Mar 1, 2022·0 cites·44 claims
- 0748US2003129607A1Compositions and methods for extension of nucleic acidsINVITROGEN CORP·Filed 2002·Application pending·0 cites
- 0837US11421021B2Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptidesINTEGRATED BIOTHERAPEUTIC VACCINES INC·Filed 2018·Granted Aug 23, 2022·0 cites·21 claims
- 0936US2018141981A1Immunogenic composition comprising engineered alpha-hemolysin oligopeptidesINTEGRATED BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Kort files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →